BioCentury
ARTICLE | Strategy

Praecis deal a lesson in matchmaking

June 9, 1997 7:00 AM UTC

Noteworthy

Praecis Pharmaceuticals Inc.'s $78 million deal with Synthelabo is a reminder that biotech companies still command leverage when they can bring a partner an advanced product that fits a particular need...